Azelastine Market Report 2025 (Global Edition)

Global Azelastine Market Report 2024 Market Size Split by Product (1% Nasal Spray, 15% Nasal Spray), by Application (Seasonal Allergic Rhinitis, Vasomotor Rhinitis), by Sales Channel (Online, Offline)...

Azelastine Market Report Description

We have various report editions of Azelastine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Azelastine Market Insights Video

Competitive Landscape of the Azelastine Market

In the azelastine market's competitive landscape, numerous key competitors are driving innovation and growth. These companies concentrate on growing their portfolios through product breakthroughs like preservative-free formulations and combination medicines. Strategic collaborations and mergers can help to preserve market positioning. The increasing frequency of allergic disorders, as well as the growing demand for over-the-counter (OTC) allergy remedies, are driving intense competition in global marketplaces.

In September 2024, Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. (Source: https://neurentmedical.com/ ) In June 2021, Bayer said today that the U.S. Food and Drug Administration (FDA) has approved Astepro® Allergy (Azelastine HCI.15%) as an over-the-counter (OTC) medicine for the temporary alleviation of nasal congestion, runny nose, sneezing, and itchy nose caused by hay fever or other upper respiratory allergies. With FDA approval, Astepro® Allergy becomes the first and only steroid-free antihistamine nasal spray for allergies accessible over-the-counter in the United States for adults and children aged six and above. (Source: https://www.fiercepharma.com/drug-delivery/bayer-lands-fda-approval-for-otc-allergy-nasal-spray-astepro#:~:text=Astepro%20is%20designed%20to%20provide,the%20first%20quarter%20of%202022.)

Top Companies Market Share in Azelastine Industry: (In no particular order of Rank)

• Apotex
• Breckenridge
• Sun Pharma
• Hikma Pharmaceuticals
• Perrigo
• Amneal Pharmaceuticals
• Alkem Labs
• Mylan
• Apotex
• Teva
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Azelastine Market

Which Region Dominates the Azelastine Market in 2024?

According to cognitive market research, North America currently dominates the azelastine market, and the region is expected to have significant growth during the projected period. Azelastine, a common antihistamine used to treat allergic rhinitis and conjunctivitis, has witnessed a surge in demand in the United States and Canada as allergy rates rise. The region's modern healthcare infrastructure facilitates greater access to allergy treatments and over-the-counter drugs, accelerating market growth.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The rising prevalence of allergic diseases, such as allergic rhinitis and conjunctivitis, has increased demand for antihistamines like azelastine. Rapid urbanization, industrialization, and pollution levels in nations like China and India contribute to an increase in respiratory allergies.

The current report Scope analyzes Azelastine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Azelastine

According to cognitive market research, the global azelastine market size was estimated at USD 1152.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 460.88 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2024 to 2031.

• According to cognitive market research, the US had a major share in the azelastine market with a market size of USD 363.63 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. The U.S. market's stringent governmental regulations against cancer treatment.
• The Canada azelastine market had a market share of USD 55.31 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. Canada’s rising awareness among the population.
• The Mexico azelastine market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 41.94 million in 2024.

Europe Azelastine

According to cognitive market research, the global azelastine market size was estimated at USD 1152.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 345.66 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2031.

• The United Kingdom azelastine market had a market share of USD 58.07 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. In the UK, azelastine sales witness an upswing due to the increasing focus on cancer treatment.
• The France azelastine market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 31.80 million in 2024.
• According to cognitive market research, the German azelastine market size was valued at USD 68.44 million in 2024 and is projected to grow at a CAGR of 4.9% during the forecast period. In Germany, azelastine surged due to the Increased focus of the manufacturers and major market players.
• The Italy azelastine market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 29.73 million in 2024.
• The Russian azelastine market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 53.58 million in 2024.
• The Spain azelastine market is projected to witness growth at a CAGR of 3.8% during the forecast period with a market size of USD 28.34 million in 2024
• The Luxembourg azelastine market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 10.72 million in 2024.
• The Portugal azelastine market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 7.26 million in 2024.
• The Greece azelastine market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 4.15 million in 2024.
• The Rest of Europe's azelastine market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 53.58 million in 2024.

Asia Pacific Azelastine

According to cognitive market research, the global azelastine market size was estimated at USD 1152.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 265.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.

• According to cognitive market research, the China azelastine market size was valued at USD 119.25 million in 2024 and is projected to grow at a CAGR of 7.7% during the forecast period. Azelastine surged in China due to the Increased focus of the manufacturers and major market players.
• The Japan azelastine market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 36.57 million in 2024.
• The India azelastine market had a market share of USD 31.80 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. India's rising awareness among the populations .
• The South Korean azelastine market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 26.50 million in 2024.
• The Australian azelastine market is projected to witness growth at a CAGR of 7.9% during the forecast period, with a market size of USD 13.78 million in 2024.
• The Southeast Asia azelastine market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 18.29 million in 2024.
• The Rest of Asia Pacific azelastine market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD 18.82 million in 2024.

South America Azelastine

According to cognitive market research, the global azelastine market size was estimated at USD 1152.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 57.61 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.

• According to cognitive market research, the Brazil azelastine market size was valued at USD 24.66 million in 2024 and is projected to grow at a CAGR of 6.2% during the forecast period. Azelastines flourished in Brazil due to increasing demand for health infrastructure.
• Argentina's azelastine market had a market share of USD 9.68 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. Argentina's rising awareness among the population.
• Colombia's azelastine market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 5.13 million in 2024.
• Peru's azelastine market is projected to witness growth at a CAGR of 5.8% during the forecast period, with a market size of USD 4.72 million in 2024.
• Chile's azelastine market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 4.15 million in 2024.
• The Rest of Latin America's azelastine market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 9.28 million in 2024.

Middle East and Africa Azelastine

According to cognitive market research, the global azelastine market size was estimated at USD 1152.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 23.04 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031..

• The GCC Countries' azelastine market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 9.86 million in 2024. Azelastine sales flourish due to the presence of major market players.
• The Egypt azelastine market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 2.42 million in 2024.
• The South Africa azelastine market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 3.64 million in 2024. Azelastine sales flourished in South Africa due to increasing demand and regulatory support.
• The Turkey azelastine market is projected to witness growth at a CAGR of 5.4% during the forecast period, with a market size of USD 1.98 million in 2024.
• The Nigeria azelastine market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 2.42 million in 2024.
• The Rest of the MEA azelastine market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 2.72 million in 2024.

Azelastine Market Analysis

Azelastine Market Product Segment Analysis

According to cognitive market research, 15% nasal spray azelastines are likely to dominate the azelastine market over the forecast period. This larger concentration appeals to those with more severe symptoms, providing a stronger effect. The increased preference for stronger therapies, particularly in areas with high allergy prevalence, has led to this segment's domination.

The 1% nasal spray is the fastest-growing segment in the azelastine market. The increase in demand can be ascribed to its ability to provide quick relief from nasal symptoms such as sneezing, itching, and congestion. Consumers looking for non-drowsy, fast-acting allergy relief will appreciate the ease of this over-the-counter option.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Azelastine Industry. Request a Free Sample PDF!

Azelastine Market Application Segment Analysis

According to cognitive market research, the seasonal allergic rhinitis segment holds the largest share of the market. Seasonal allergic rhinitis, also known as hay fever, affects a larger percentage of the population, particularly during seasons when allergens such as pollen are widespread. Azelastine, an antihistamine, is commonly used to treat sneezing, nasal congestion, and itchy eyes caused by this illness.

In the azelastine market, vasomotor rhinitis has been expanding at a rapid pace. Vasomotor rhinitis, in particular, is becoming the fastest-growing sector due to increased awareness and diagnosis rates. Unlike allergic rhinitis, which is induced by allergens, VMR is caused by irritants such as fragrances, smoke, or weather changes, making it more difficult to treat.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Azelastine Sales Channel Segment Analysis

Azelastine Market Sales Channel Segment Analysis

According to cognitive market research, the offline segment holds the largest market share. Especially through pharmacies, hospitals, and healthcare facilities. The offline category has a bigger market share because it is the more conventional channel for prescription drug sales, particularly in areas where access to digital platforms is limited, or healthcare regulations require physical purchases from certified stores.

In the azelastine market, the rapidly growing sector is the online category. This spike is largely due to the growing popularity of online shopping platforms, which provide convenience, a diverse product variety, and competitive pricing. Consumers are increasingly choosing to buy prescriptions like Azelastine online due to the convenience and availability of savings.

• Online
• Offline

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion